Fig. 2From: Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort studyKaplan-Meier curves showing the cumulative incidence of hepatocellular carcinoma (HCC) in hepatitis C virus carriers with or without aspirin treatment. Red line presents aspirin users. Black line presents non-aspirin users. X-axis presents follow-up years. Y-axis presents cumulative incidence of hepatocellular carcinomaBack to article page